Recurrent Pyogenic Cholangitis: Efficacy of Two-Phase Helical CT

ABSTRACT

PURPOSE: To evaluate the usefulness of two-phase helical CT in patients with recurrent pyogenic cholangitis (RPC) for the detection of acute inflammation and assessment of the degree of portal vein (PV) stenosis as a cause of hepatic parenchymal atrophy. MATERIALS AND METHODS: We retrospectively reviewed two-phase CT findings in 30 patients with RPC diagnosed by CT, ERCP (endoscopic retrograde cholangiopancreatography), and surgery. Two-phase helical CT scans were obtained 30 sec (arterial phase, AP) and 70 sec (portal phase, PP) after the start of IV administration of contrast material. Without prior information, we analyzed periductal parenchymal and ductal wall enhancement during the AP and PP, and the degree of PV stenosis during the PP. Acute inflammation was diagnosed on the basis of symptoms and laboratory findings. To evaluate the relationship between parenchymal atrophy and PV stenosis, the degree of PV stenosis in affected parenchyma was classified as one of three types (mild,75%), as compared with the diameter of normal PV in unaffected parenchyma. RESULTS: Ten of the 30 patients underwent CT during the acute inflammatory stage and 20 during the remission stage. Of the ten patients with acute inflammation, eight (80%) showed transient periductal parenchymal enhancement during the AP (p0.05). There was no significant difference in parenchymal and ductal wall enhancement during the PP between patients with acute inflammation and those who showed remission (p>0.05). Hepatic parenchymal atrophy of the lesion was seen in 24 patients. Among these, PV stenosis was mild in five (21%), moderate in 14 (58%), and severe in five (21%). Degree of PV stenosis correlated closely with severity of parenchymal atrophy during the PP. In six patients without parenchymal atrophy, PV caliber was normal. CONCLUSION: Our results suggest that in patients with RPC, two-phase helical CT is useful for the detection of transient periductal parenchymal enhancement accompanying acute inflammation during the AP, and for assessment of the degree of PV stenosis as a cause of hepatic parenchymal atrophy during the PP.